Continuation of Research and Development Activities
First written in FY2017-Q1. 19 of 25 entries say "Restated". Latest entry: FY2026.
45 other companies' latest entry also says "Advanced".
- FY2026AdvancedAnnual report
「The company is developing cyclic carbonate, a monomer for CO2-based hydroxypolyurethane (HPU), as part of NEDO's Green Innovation Fund Project. In February 2026, it began trial operations of the pilot plant.」
For CO2-based HPU, the project has progressed from starting construction to beginning trial operations of the pilot plant. - FY2026-H1AdvancedAnnual report
「Group-wide R&D expenses for the current interim consolidated accounting period were ¥522 million, while technology-related expenses incurred for improvements to existing products and other purposes amounted to ¥878 million. From 1 April 2025, the company revamped its technology organization, changing from the former structure organized vertically by technology held to an organizational structure based on development stages. At the same time, it integrated this structure with the technology divisions of the business organization, which conduct development in direct collaboration with customers, and strengthened its technology and product development capabilities through open innovation and other initiatives, changing to a structure capable of creating businesses driven by technology.」
The company disclosed R&D expenses of ¥522 million and technology-related expenses of ¥878 million, and described the organizational changes effective 1 April 2025, including the shift to an organization based on development stages, integration with the technology divisions of the business organization, and the incorporation of open innovation, as significant changes during the current interim consolidated accounting period. - FY2025AdvancedAnnual report
「The company is developing cyclic carbonate, a monomer for CO2-based hydroxypolyurethane (HPU), as part of NEDO's Green Innovation Fund Project. Laboratory evaluations are progressing smoothly, and construction of a pilot plant has begun, targeting start-up in March 2026.」
Regarding R&D activities, the company is advancing laboratory evaluations of CO2-based HPU, has begun construction of a pilot plant, and is targeting start-up in March 2026. - FY2024AdvancedAnnual report
「Research and development expenses by segment for the fiscal year were ¥1,546 million for Color & Functional Products, ¥1,024 million for Polymer & Coating Materials, and ¥461 million for Graphic & Printing Materials, for a total of ¥3,032 million.」
The company disclosed that it continued its R&D activities, with annual R&D expenses of ¥3,032 million (¥2,972 million in the previous year, up 2.0%), and that it was advancing product development in 4 priority areas. - FY2024-Q2RestatedAnnual report
「The Group's total research and development expenditure during the second quarter of the current consolidated cumulative period was ¥1,483 million. There were no material changes in the status of the Group's research and development activities during the period.」
The company disclosed that it continued its research and development activities, with research and development expenditure of ¥1,483 million for the second-quarter consolidated cumulative period and no material changes in the status of the activities. - FY2023-Q3RestatedAnnual report
「The Group's total research and development expenditure during the third quarter of the current consolidated cumulative period was ¥2,295 million. There were no material changes in the status of the Group's research and development activities during the period.」
The company disclosed research and development expenditure of ¥2,295 million for the third-quarter consolidated cumulative period and stated that there were no material changes in the status of the research and development activities. - FY2023-Q2RestatedAnnual report
「The Group's total research and development expenditure during the second quarter of the current consolidated cumulative period was ¥1,520 million. There were no material changes in the status of the Group's research and development activities during the period.」
The company disclosed research and development expenditure of ¥1,520 million for the second-quarter consolidated cumulative period and stated that there were no material changes in the status of the research and development activities. - FY2022-Q3RestatedAnnual report
「The Group's total research and development expenditure during the third quarter of the current consolidated cumulative period was ¥2,113 million. There were no material changes in the status of the Group's research and development activities during the period.」
The company disclosed that it continued its research and development activities, with research and development expenditure of ¥2,113 million for the third-quarter consolidated cumulative period and no material changes in the status of the activities. - FY2022-Q1RestatedAnnual report
「The Group's total research and development expenditure during the first quarter of the current consolidated cumulative period was ¥699 million. There were no material changes in the status of the Group's research and development activities during the period.」
The company disclosed research and development expenditure of ¥699 million for the first-quarter consolidated cumulative period and stated that there were no material changes in the status of the research and development activities. - FY2021-Q3RestatedAnnual report
「The Group's total research and development expenditure during the third quarter of the current consolidated cumulative period was ¥2,044 million. There were no material changes in the status of the Group's research and development activities during the period.」
The company disclosed research and development expenditure of ¥2,044 million for the third-quarter consolidated cumulative period and stated that there were no material changes in the status of the research and development activities. - FY2021-Q2RestatedAnnual report
「The Group's total research and development expenditure during the second quarter of the current consolidated cumulative period was ¥1,357 million. There were no material changes in the status of the Group's research and development activities during the period.」
The company disclosed research and development expenditure of ¥1,357 million for the second-quarter consolidated cumulative period and stated that there were no material changes in the status of the research and development activities. - FY2021-Q1RestatedAnnual report
「The Group's total research and development expenditure during the first quarter of the current consolidated cumulative period was ¥704 million. There were no material changes in the status of the Group's research and development activities during the period.」
The company disclosed that it continued its research and development activities, with research and development expenditure of ¥704 million for the first-quarter consolidated cumulative period and no material changes in the status of the activities. - FY2020AdvancedAnnual report
「Total research and development expenditure for the current consolidated fiscal year was ¥2,992 million.」
The company disclosed that it continued its research and development activities, with annual research and development expenditure of ¥2,992 million and focused investment in the environment, energy, personal care, IT and electronics fields. - FY2020-Q3RestatedAnnual report
「The Group's total research and development expenditure during the third quarter of the current consolidated cumulative period was ¥2,270 million. There were no material changes in the status of the Group's research and development activities during the period.」
Research and development expenditure was ¥2,270 million for the third-quarter consolidated cumulative period, with no material changes in the status of the activities. - FY2020-Q2RestatedAnnual report
「The Group's total research and development expenditure during the second quarter of the current consolidated cumulative period was ¥1,522 million. There were no material changes in the status of the Group's research and development activities during the period.」
Research and development expenditure was ¥1,522 million for the second-quarter consolidated cumulative period, with no material changes in the status of the activities. - FY2020-Q1RestatedAnnual report
「The Group's total research and development expenditure during the first quarter of the current consolidated cumulative period was ¥759 million. There were no material changes in the status of the Group's research and development activities during the period.」
Research and development expenditure was ¥759 million for the first-quarter consolidated cumulative period, with no material changes in the status of the activities. - FY2019-Q3RestatedAnnual report
「The Group's total research and development expenditure during the third quarter of the current consolidated cumulative period was ¥2,323 million. There were no material changes in the status of the Group's research and development activities during the period.」
Research and development expenditure was ¥2,323 million for the third-quarter consolidated cumulative period, with no material changes in the status of the research and development activities. - FY2019-Q2RestatedAnnual report
「The Group's total research and development expenditure during the second quarter of the current consolidated cumulative period was ¥1,500 million. There were no material changes in the status of the Group's research and development activities during the period.」
Research and development expenditure was ¥1,500 million for the second-quarter consolidated cumulative period, with no material changes in the status of the activities. - FY2019-Q1RestatedAnnual report
「The Group's total research and development expenditure during the first quarter of the current consolidated cumulative period was ¥735 million. There were no material changes in the status of the Group's research and development activities during the period.」
Research and development expenditure was ¥735 million for the first-quarter consolidated cumulative period, with no material changes in the status of the activities. - FY2018-Q3RestatedAnnual report
「The Group's total research and development expenditure during the third quarter of the current consolidated cumulative period was ¥2,196 million. There were no material changes in the status of the Group's research and development activities during the period.」
Research and development expenditure was ¥2,196 million for the third-quarter consolidated cumulative period, with no material changes in the status of the activities. - FY2018-Q2RestatedAnnual report
「The Group's total research and development expenditure during the second quarter of the current consolidated cumulative period was ¥1,615 million. There were no material changes in the status of the Group's research and development activities during the period.」
Research and development expenditure was ¥1,615 million for the second-quarter consolidated cumulative period, with no material changes in the status of the activities. - FY2018-Q1RestatedAnnual report
「The Group's total research and development expenditure during the first quarter of the current consolidated cumulative period was ¥732 million. There were no material changes in the status of the Group's research and development activities during the period.」
Research and development expenditure was ¥732 million for the first-quarter consolidated cumulative period, with no material changes in the status of the activities. - FY2017-Q3RestatedAnnual report
「The Group's total research and development expenditure during the third quarter of the current consolidated cumulative period was ¥2,322 million. There were no material changes in the status of the Group's research and development activities during the period.」
Research and development expenditure was ¥2,322 million for the third-quarter consolidated cumulative period, with no material changes in the status of the activities. - FY2017-Q2RestatedAnnual report
「The Group's total research and development expenditure during the second quarter of the current consolidated cumulative period was ¥1,528 million. There were no material changes in the status of the Group's research and development activities during the period.」
Research and development expenditure was ¥1,528 million for the quarter-to-date period, with no material changes in the status of the activities. - FY2017-Q1First statedAnnual report
「The Group's total research and development expenditure during the first quarter of the current consolidated cumulative period was ¥749 million. There were no material changes in the status of the Group's research and development activities during the period.」
The Group conducted ¥749 million of research and development during the quarter-to-date period, with no material changes in the status of its activities.